Halting translation by the letter with sequence-selective small molecules.
Sequence-selective small molecules can precisely halt translation by targeting specific RNA or peptide sequences in eukaryotic cells.
- Why it matters: Understanding how to selectively modulate translation is crucial for developing targeted therapies and dissecting the complex mechanisms of protein synthesis, which are fundamental to cellular function and disease.
- What they did: The review summarizes recent discoveries of sequence-specific translation modulators in eukaryotes, highlighting advanced sequencing and structural techniques that facilitated their identification and characterization.
- The result: These findings open new avenues for controlling protein expression with high specificity, enabling potential therapeutic strategies and deeper insights into translation regulation.